Abstract
A rapid liquid chromatographic method with electrospray ionization tandem mass spectrometric detection has been developed and validated for quantification of quetiapine in heparinized human plasma. Plasma samples, without a drying and reconstitution step, were extracted by solid-phase extraction and eluted with acetonitrile. The analyte and zolpidem tartrate (internal standard, IS) were chromatographed on a C18 column; the mobile phase was 85:15 (v/v) acetonitrile–5 mM ammonium formate, pH adjusted to 4.5 with formic acid, at a flow rate of 0.5 mL min−1. The retention times of quetiapine and the IS were 1.25 and 1.05 min, respectively, and the run time was 1.8 min per sample. Selected reaction monitoring of MH+ at m/z 384.12 and 308.11 resulted in stable fragment ions with m/z 253.02 and 235.09 for quetiapine and the IS, respectively. Response was a linear function of concentration in the range 1.0–240.0 ng mL−1, with r ≥ 0.9994. Recovery of quetiapine and the IS ranged from 74.82 to 85.57%. The assay has excellent characteristics and has been successfully used for analysis of quetiapine in healthy human subjects in a bioequivalence study.
Similar content being viewed by others
References
Physicians Desk Reference (PDR) (2007) Medicines Economics Inc., 61st edn. Montvale, pp 690–695. http://www.PDR.net
Seroquel (quetiapine fumarate) tablets, AstraZeneca Pharmaceuticals LP Wilmington, FE 19850, Made in USA. http://www.fda.govt/MEDwatch/SAFETY/2004/Seroquel-lbl.pdf
DeVane CL, Nemeroff CB (2001) Clin Pharmacokinet 40:509–522
Hasselstrom J, Linnet K (2003) J Chromatogr B 798:9–16
Pullen RH, Palermo KM, Curtis MA (1992) J Chromatogr 573:49–57
Davis PC, Wong J, Gefvert O (1999) J Pharm Biomed Anal 20:271–282
Mandrioli R, Fanali S, Ferranti A, Raggi MA (2002) J Pharm Biomed Anal 30:969–977
Frahnert C, Rao ML, Grasmaeder K (2003) J Chromatogr B 794:35–47
Anderson DT, Fritz KL (2000) J Anal Toxicol 24:300–304
Pelander A, Ojanpera I, Sistonen J, Rasenen I, Vuori E (2003) J Anal Toxicol 27:226–232
Kun-yan L, Ze-neng C, Xin L, Xue-lian B, Bi-kue Z, Feng W, Huan-de L (2004) Acta Pharm Sin 25(1):110–114. http://www.ChinaPhar.com
Zhou Z, Li X, Li K, Xie Z, Cheng Z, Peng W, Wang F, Zhu R, Li H (2004) J Chromatogr B 802:257–262
Barrett B, Holcapek M, Huclova J, Borek-Dohalsky V, Fejt P, Nemec B, Jelinek I (2007) J Pharm Biomed Anal 44:498–505
Lin S-N, Chang Y, Moody DE, Foltz RL (2004) J Anal Toxicol 28:443–448
US Department of Health and Human Services (2001) Bioanalytical method validation guidance for industry. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for veterinary Medicines. http://www.fda.govt./cder/guidance/4252fnl.htm
Acknowledgments
The authors are indebted to Dr. Chaitanya Dutt, Director, Torrent Research Centre, for his continuous support. The authors gratefully acknowledge Torrent Research Centre for providing the facilities necessary to carry out this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kundlik, M.L., Kambli, S., Shah, V. et al. Quantification of Quetiapine in Human Plasma by LC–MS–MS. Chroma 70, 1587–1592 (2009). https://doi.org/10.1365/s10337-009-1353-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-009-1353-z